Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
KDM5B predicts temozolomide-resistant subclones in glioblastoma.
Ullrich V, Ertmer S, Baginska A, Dorsch M, Gull HH, Cima I, Berger P, Dobersalske C, Langer S, Meyer L, Dujardin P, Kebir S, Glas M, Blau T, Keyvani K, Rauschenbach L, Sure U, Roesch A, Grüner BM, Scheffler B. Ullrich V, et al. Among authors: blau t. iScience. 2023 Dec 3;27(1):108596. doi: 10.1016/j.isci.2023.108596. eCollection 2024 Jan 19. iScience. 2023. PMID: 38174322 Free PMC article.
Feasibility and tolerability of trofosfamide and etoposide in progressive glioblastoma.
Schmidt T, Agkatsev S, Feldheim J, Oster C, Blau T, Sure U, Keyvani K, Kleinschnitz C, Stuschke M, Herrmann K, Deuschl C, Scheffler B, Kebir S, Glas M, Lazaridis L. Schmidt T, et al. Among authors: blau t. Neurooncol Adv. 2023 Jul 20;5(1):vdad090. doi: 10.1093/noajnl/vdad090. eCollection 2023 Jan-Dec. Neurooncol Adv. 2023. PMID: 37547266 Free PMC article.
Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
Milosevic A, Styczen H, Haubold J, Kessler L, Grueneisen J, Li Y, Weber M, Fendler WP, Morawitz J, Damman P, Wrede K, Kebir S, Glas M, Guberina M, Blau T, Schaarschmidt BM, Deuschl C. Milosevic A, et al. Among authors: blau t. Nucl Med Commun. 2023 Dec 1;44(12):1106-1113. doi: 10.1097/MNM.0000000000001774. Epub 2023 Oct 12. Nucl Med Commun. 2023. PMID: 37823259
Longitudinal impact of intracerebral low-grade glioma disease on health-related quality of life.
Rauschenbach L, Bartsch P, Santos AN, Michel A, Gull HH, Ketelauri P, Darkwah Oppong M, Schmidt B, Dobersalske C, Blau T, Ahmadipour Y, Jabbarli R, Wrede KH, Sure U, Dammann P. Rauschenbach L, et al. Among authors: blau t. J Neurosurg Sci. 2024 Mar 14. doi: 10.23736/S0390-5616.23.06107-6. Online ahead of print. J Neurosurg Sci. 2024. PMID: 38483435
Fully automated MR-based virtual biopsy of primary CNS lymphomas.
Parmar V, Haubold J, Salhöfer L, Meetschen M, Wrede K, Glas M, Guberina M, Blau T, Bos D, Kureishi A, Hosch R, Nensa F, Forsting M, Deuschl C, Umutlu L. Parmar V, et al. Among authors: blau t. Neurooncol Adv. 2024 Mar 14;6(1):vdae022. doi: 10.1093/noajnl/vdae022. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38516329 Free PMC article.
Evaluation of [68Ga]-DOTATOC PET/MRI in Patients with Meningioma of the Subcranial and Intraorbital Space.
Milosevic A, Styczen H, Grueneisen J, Li Y, Weber M, Fendler WP, Kirchner J, Damman P, Wrede K, Lazaridis L, Glas M, Guberina M, Eckstein A, Blau T, Herrmann K, Umutlu L, Forsting M, Deuschl C, Schaarschmidt B. Milosevic A, et al. Among authors: blau t. J Nucl Med. 2023 Aug;64(8):1185-1190. doi: 10.2967/jnumed.123.265424. Epub 2023 Jun 29. J Nucl Med. 2023. PMID: 37385668
Machine Learning for Biological Design.
Blau T, Chades I, Ong CS. Blau T, et al. Methods Mol Biol. 2024;2760:319-344. doi: 10.1007/978-1-0716-3658-9_19. Methods Mol Biol. 2024. PMID: 38468097
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNA.
Heger JM, Mattlener J, Schneider J, Gödel P, Sieg N, Ullrich F, Lewis R, Bucaciuc-Mracica T, Schwarz RF, Rueß D, Ruge MI, Montesinos-Rongen M, Deckert M, Blau T, Kutsch N, Balke-Want H, Weiss J, Becker K, Reinhardt HC, Hallek M, Borchmann P, von Tresckow B, Borchmann S. Heger JM, et al. Among authors: blau t. Blood. 2024 Feb 8;143(6):522-534. doi: 10.1182/blood.2023022020. Blood. 2024. PMID: 37946299
Location of Recurrences after Trimodality Treatment for Glioblastoma with Respect to the Delivered Radiation Dose Distribution and Its Influence on Prognosis.
Guberina N, Padeberg F, Pöttgen C, Guberina M, Lazaridis L, Jabbarli R, Deuschl C, Herrmann K, Blau T, Wrede KH, Keyvani K, Scheffler B, Hense J, Layer JP, Glas M, Sure U, Stuschke M. Guberina N, et al. Among authors: blau t. Cancers (Basel). 2023 May 30;15(11):2982. doi: 10.3390/cancers15112982. Cancers (Basel). 2023. PMID: 37296942 Free PMC article.
59 results